Eigenkapital Und Reserven Veränderung Datum
3M USD 2.95B 311M 2026-06
Abbott USD 52.06B 69M 2026-03
AngioDynamics USD 176.33M 2.52M 2025-09
Anika Therapeutics USD 137.28M 3.38M 2026-06
AtriCure USD 516.43M 24.74M 2026-06
Baxter International USD 6.21B 163M 2026-06
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Boston Scientific USD 24.93B 934M 2026-06
Cooper Companies USD 8.36B 124.7M 2025-12
Dexcom USD 2.62B 335.5M 2026-06
Edwards Lifesciences USD 10.62B 290.5M 2026-06
Globus Medical USD 4.77B 36.29M 2026-06
Haemonetics USD 837.1M 40.78M 2026-06
ICU Medical USD 2.15B 39.92M 2026-06
Insulet USD 1.42B 119.6M 2026-06
Integra LifeSciences USD 1.04B 971K 2026-06
J&J USD 84.97B 3.78B 2026-06
Medtronic USD 48.99B 128M 2025-12
Merit Medical Systems USD 1.68B 53.08M 2026-06
Olympus JPY 747.9B 64.14B 2026-06
Pfizer USD 85.19B 4.91B 2026-06
STAAR Surgical USD 352.37M 8.18M 2026-03
Stryker USD 22.98B 559M 2026-03
Tandem Diabetes Care USD 130.39M 2.02M 2026-06
Teleflex USD 2.9B 179.9M 2026-06
Terumo JPY 1.66T 77.51B 2026-06
Zimmer Biomet Holdings USD 12.63B 49.1M 2026-06